Evidence map›Paper›PMID 35632585›Full record

ArticleVaccines2022

Impact of the Threat of COVID-19 Infections on the Perceived Risk to HPV Vaccination.

Yumi Shimizu, Kei Hirai, Yutaka Ueda, Asami Yagi, Fumio Ohtake

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yumi ShimizuDepartment of Clinical Psychology, Graduate School of Human Sciences, Osaka University, 1-2, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0003-0413-8704
Kei HiraiDepartment of Clinical Psychology, Graduate School of Human Sciences, Osaka University, 1-2, Yamadaoka, Suita 565-0871, Osaka, Japan.
Yutaka UedaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0001-8760-6379
Asami YagiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan.
Fumio OhtakeDepartment of Economics, Graduate School of Economics, Osaka University, 1-7, Machikaneyama-cho, Toyonaka 560-0043, Osaka, Japan.ORCID 0000-0002-8825-7446
The University of Osaka · JPOsaka University of Economics · JP

Funding

Health and Labor Sciences Research Grant 202008053AJSPS KAKENHI JP20H05632
6 · The paper itself

Abstract

Vaccination rates for human papillomavirus (HPV) in Japan are significantly lower than other countries, and Japanese people are reluctant to be vaccinated. Repeated daily reports of COVID-19 infections and restrictions have made people more health conscious and aware of the danger of infectious diseases. In this study, we used the health belief model (HBM) to examine perceived threats of cancer and infectious diseases and to ascertain whether the new COVID-19 vaccination in addition to these perceived threats would increase vaccination intention against cervical cancer. We conducted a cluster analysis to classify the segmentation regarding the perceived threat, and a logistic regression analysis to predict factors influencing people accepting vaccination. We received 1257 completed surveys during our research. We classified the participants into six clusters, and the logistic regression analysis indicated eight factors significantly associated with the willingness to get the HPV vaccine: reliable information sources such as doctors and social networking sites (SNS), the recognition of COVID-19 symptoms, the awareness of COVID-19 vaccination, the importance of HPV prevention through vaccination, one's own intention of COVID-19 vaccination, their intention of COVID-19 vaccination toward children, and benefits of HPV vaccination. Further research on HPV and COVID-19 vaccination is encouraged.

Indexed as

cervical cancerCOVID-19 vaccinehealth belief modelhealth consciousnessHPV vaccinevaccination statusvaccine willingness

Identifiers

PMID35632585
PMCPMC9147999
OpenAlexW4281559033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.